Tivity Health (NASDAQ:TVTY) was downgraded by equities research analysts at TheStreet from a “b” rating to a “c+” rating in a research report issued to clients and investors on Wednesday.
Several other brokerages have also recently weighed in on TVTY. Zacks Investment Research raised Tivity Health from a “hold” rating to a “buy” rating and set a $44.00 target price for the company in a research note on Saturday, November 10th. Barrington Research reiterated a “buy” rating and issued a $50.00 price target on shares of Tivity Health in a research report on Tuesday, November 6th. ValuEngine upgraded Tivity Health from a “sell” rating to a “hold” rating in a research report on Tuesday, November 6th. Chardan Capital decreased their price target on Tivity Health from $43.00 to $41.00 and set a “buy” rating for the company in a research report on Tuesday, November 6th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $49.00 price target on shares of Tivity Health in a research report on Monday, November 5th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $42.29.
Shares of TVTY stock opened at $24.81 on Wednesday. Tivity Health has a fifty-two week low of $23.71 and a fifty-two week high of $44.35. The stock has a market cap of $998.20 million, a P/E ratio of 14.77, a PEG ratio of 0.94 and a beta of 1.24. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.15.
Tivity Health (NASDAQ:TVTY) last announced its earnings results on Monday, November 5th. The company reported $0.59 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.57 by $0.02. Tivity Health had a return on equity of 28.25% and a net margin of 13.29%. The business had revenue of $151.50 million during the quarter, compared to analysts’ expectations of $153.87 million. During the same quarter last year, the business posted $0.46 earnings per share. The company’s quarterly revenue was up 10.0% on a year-over-year basis. As a group, sell-side analysts predict that Tivity Health will post 2.18 EPS for the current fiscal year.
In related news, CEO Donato Tramuto sold 35,000 shares of the stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $38.25, for a total value of $1,338,750.00. Following the completion of the transaction, the chief executive officer now owns 334,743 shares in the company, valued at approximately $12,803,919.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.73% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. NEXT Financial Group Inc purchased a new stake in Tivity Health in the 3rd quarter worth about $104,000. Stone Ridge Asset Management LLC purchased a new stake in Tivity Health in the 3rd quarter worth about $213,000. Pacer Advisors Inc. lifted its stake in Tivity Health by 143.3% in the 3rd quarter. Pacer Advisors Inc. now owns 6,759 shares of the company’s stock worth $217,000 after acquiring an additional 3,981 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Tivity Health by 31.7% in the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,551 shares of the company’s stock worth $307,000 after acquiring an additional 2,297 shares in the last quarter. Finally, PEAK6 Investments LLC purchased a new stake in Tivity Health in the 3rd quarter worth about $310,000.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Read More: What Is An Exchange-Traded Fund (ETF)?
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.